Neurologists’ Openness to Evidence-Based Innovation in Multiple Sclerosis Care: Individual and Structural Determinants
Enric Monreal,1 Rocío Gómez-Ballesteros,2 Virginia Meca-Lallana,3 Ana B Caminero,4 Jose E Meca-Lallana,5 Sergio Martínez-Yélamos,6 Lamberto Landete,7 Jose M García-Domínguez,8 Eduardo Agüera,9 Elena García-Arcelay,2 Nicolas Medrano,2 Luisa M Villar,10 Jorge Maurino2 1Department of Neurology, Hospita...
Saved in:
| Main Authors: | Monreal E, Gómez-Ballesteros R, Meca-Lallana V, Caminero AB, Meca-Lallana JE, Martínez-Yélamos S, Landete L, García-Domínguez JM, Agüera E, García-Arcelay E, Medrano N, Villar LM, Maurino J |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-07-01
|
| Series: | Neuropsychiatric Disease and Treatment |
| Subjects: | |
| Online Access: | https://www.dovepress.com/neurologists-openness-to-evidence-based-innovation-in-multiple-scleros-peer-reviewed-fulltext-article-NDT |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corrigendum: Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosis
by: Fernando Rodríguez-Jorge, et al.
Published: (2024-12-01) -
20841. IMPACTO DE UN PROGRAMA DE REHABILITACIÓN VIRTUAL EN LA SATISFACCIÓN DE PACIENTES CON ESCLEROSIS MÚLTIPLE (ESTUDIO REHABVR)
by: V. Meca Lallana, et al.
Published: (2024-11-01) -
Inflammatory bowel disease and multiple sclerosis
by: M. Dominguez-Gallego, et al.
Published: (2025-07-01) -
20839. EVALUACIÓN A MEDIO PLAZO DE EVOLUCIÓN EN PACIENTES NEDA CON NEUROFILAMENTOS SÉRICOS COMO FACTOR PRONÓSTICO
by: V. Meca Lallana, et al.
Published: (2024-11-01) -
20696. DESARROLLO E IMPLEMENTACIÓN DE UN ALGORITMO CLÍNICO ASISTENCIAL PARA LA DETECCIÓN DE PROGRESIÓN EN ESCLEROSIS MÚLTIPLE: PROYECTO RETRATEMOS
by: J. Meca Lallana, et al.
Published: (2024-11-01)